Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 77Unknown 11Recruiting 11Active not recruiting 6Terminated 3Not yet recruiting 3Withdrawn 2

Sponsor Class

OTHER 2UNKNOWN 1

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 332Neoplasms 221Prostatic Neoplasms 197Carcinoma, Non-Small-Cell Lung 156Lung Neoplasms 134Pancreatic Neoplasms 118Colorectal Neoplasms 102Neoplasm Metastasis 100Carcinoma, Hepatocellular 96Leukemia, Myeloid, Acute 94Multiple Myeloma 91Brain Neoplasms 89Lymphoma 86Head and Neck Neoplasms 76Melanoma 73Ovarian Neoplasms 72Leukemia 71Leukemia, Lymphocytic, Chronic, B-Cell 69Glioblastoma 69Precursor Cell Lymphoblastic Leukemia-Lymphoma 66Colonic Neoplasms 61Recurrence 59Lymphoma, Non-Hodgkin 54Rectal Neoplasms 50Hematologic Neoplasms 50Lymphoma, Follicular 49Glioma 49Squamous Cell Carcinoma of Head and Neck 47Lymphoma, Large B-Cell, Diffuse 47Carcinoma, Renal Cell 46

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Advanced Cancer × Clear all
NCT03122249 2024-05-08

OASIS

University of Iowa

Phase NA Withdrawn

Advanced Cancer

NCT05262842 2022-09-21

JS001+IMP4297 in Patients With Advanced Cancer

Shanghai Junshi Bioscience Co., Ltd.

Phase 1 Withdrawn

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡